EUVIMEDEUVIMED entdecken
Crossref

A Dual‐Function CD47‐Targeting Nano‐Drug Delivery System Used to Regulate Immune and Anti‐Inflammatory Activities in the Treatment of Atherosclerosis

Huanhuan Wang, Runze Zhao iD, Lei Peng, Ao Yu, Yongjian Wang iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202400752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Huanhuan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China. Hauptthemen laut MEDLINE: Atherosclerosis, CD47 Antigen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Haihe Laboratory of Sustainable Chemical Transformations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a primary contributor to cardiovascular disease. Current studies have highlighted the association between the immune system, particularly immune cells, and atherosclerosis, although treatment options and clinical trials remain scarce. Immunotherapy for cardiovascular disease is still in its infancy. Bruton's tyrosine kinase (BTK), widely expressed in various immune cells, represents a promising therapeutic target for atherosclerosis by modulating the anti‐inflammatory function of immune cells. This study introduces a polydopamine‐based nanocarrier system to deliver the BTK inhibitor, ibrutinib, to atherosclerotic plaques with an active targeting property via an anti‐CD47 antibody. Leveraging polydopamine's pH‐sensitive reversible disassembly, the system offers responsive, controlled release within the pathologic microenvironment. This allows precise and efficient ibrutinib delivery, concurrently inhibiting the activation of the NF‐κB pathway in B cells and the NLRP3 inflammasome in macrophages within the plaques. This treatment also modulates both the immune cell microenvironment and inflammatory conditions in atherosclerotic lesions, thereby conveying promising therapeutic effects for atherosclerosis in vivo. This strategy also provides a novel option for atherosclerosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCD47 AntigenAnimalsMiceAnti-Inflammatory AgentsAdeninePiperidinesMacrophagesMice, Inbred C57BLHumansNLR Family, Pyrin Domain-Containing 3 ProteinAgammaglobulinaemia Tyrosine KinasePlaque, AtheroscleroticNF-kappa BInflammasomesNanoparticle Drug Delivery SystemDrug Delivery SystemsPyrimidinesPyrazoles

Stichwörter der Autor:innen

atherosclerosisbruton's tyrosine kinaseimmune cellsnano‐drug delivery systempolydopamine

Substanzen

CD47 AntigenAnti-Inflammatory AgentsibrutinibAdeninePiperidinesNLR Family, Pyrin Domain-Containing 3 ProteinAgammaglobulinaemia Tyrosine KinaseNF-kappa BInflammasomesNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, 300071, China.
  • Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
  • Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin, 300071, China.

ORCID-Profile: Runze Zhao, Yongjian Wang

Förderung

  • National Natural Science Foundation of China
  • Haihe Laboratory of Sustainable Chemical Transformations

Zitieren

APA

Wang, H., Zhao, R., Peng, L., Yu, A., & Wang, Y. (2024). A Dual‐Function CD47‐Targeting Nano‐Drug Delivery System Used to Regulate Immune and Anti‐Inflammatory Activities in the Treatment of Atherosclerosis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400752

Vancouver

Wang H, Zhao R, Peng L, Yu A, Wang Y. A Dual‐Function CD47‐Targeting Nano‐Drug Delivery System Used to Regulate Immune and Anti‐Inflammatory Activities in the Treatment of Atherosclerosis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400752

BibTeX
@article{Wang2024,
  author = {Wang, Huanhuan and Zhao, Runze and Peng, Lei and Yu, Ao and Wang, Yongjian},
  title = {A Dual‐Function CD47‐Targeting Nano‐Drug Delivery System Used to Regulate Immune and Anti‐Inflammatory Activities in the Treatment of Atherosclerosis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202400752}
}
Kostenlos starten →